Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASTHOTCMKTS:BEVFFNASDAQ:GDRXNYSE:VVX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTHAstrana Health$25.19+2.8%$29.44$23.12▼$63.20$1.41B1291,128 shs196,061 shsBEVFFDiversified Royalty$2.14+0.2%$2.04$1.73▼$2.25$362.46M0.8112,593 shs2,196 shsGDRXGoodRx$3.94+3.1%$4.27$3.68▼$9.26$1.41B1.241.37 million shs617,856 shsVVXV2X$44.79+2.4%$48.34$41.08▼$69.75$1.42B0.27203,612 shs284,082 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTHAstrana Health-2.39%+0.86%-24.59%-8.51%-40.86%BEVFFDiversified Royalty-0.16%+1.16%+2.17%+13.23%+6.36%GDRXGoodRx-2.30%+2.14%-18.38%-18.20%-51.46%VVXV2X-3.27%-3.82%-11.36%-3.57%-8.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTHAstrana Health3.8719 of 5 stars3.34.00.00.02.11.73.1BEVFFDiversified Royalty0.3916 of 5 stars0.01.01.70.00.00.81.3GDRXGoodRx3.2062 of 5 stars3.32.00.00.03.71.71.9VVXV2X3.9211 of 5 stars3.33.00.00.03.92.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTHAstrana Health 2.67Moderate Buy$53.29111.54% UpsideBEVFFDiversified Royalty 2.00HoldN/AN/AGDRXGoodRx 2.64Moderate Buy$6.5566.13% UpsideVVXV2X 2.60Moderate Buy$63.6742.14% UpsideCurrent Analyst Ratings BreakdownLatest BEVFF, VVX, ASTH, and GDRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025GDRXGoodRxUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.255/9/2025GDRXGoodRxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.004/29/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.004/16/2025VVXV2XMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageUnderweight$51.004/14/2025VVXV2XTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$68.00 ➝ $55.004/10/2025GDRXGoodRxTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$6.50 ➝ $5.504/1/2025ASTHAstrana HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$36.003/25/2025BEVFFDiversified RoyaltyCIBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral3/18/2025ASTHAstrana HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$50.00 ➝ $46.003/4/2025ASTHAstrana HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$55.00 ➝ $49.003/3/2025ASTHAstrana HealthRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$86.00 ➝ $50.00(Data available from 6/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTHAstrana Health$2.25B0.63$0.96 per share26.15$10.58 per share2.38BEVFFDiversified Royalty$41.85M8.66$0.18 per share12.09$1.22 per share1.76GDRXGoodRx$797.41M1.76$0.33 per share11.77$1.93 per share2.04VVXV2X$4.33B0.33$7.94 per share5.64$31.76 per share1.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTHAstrana Health$60.72M$0.7219.3817.871.373.63%9.37%5.32%8/6/2025 (Estimated)BEVFFDiversified Royalty$23.50M$0.1314.30∞N/A49.26%11.44%5.52%8/7/2025 (Estimated)GDRXGoodRx-$8.87M$0.08N/A21.892.46-2.05%5.35%2.51%8/7/2025 (Estimated)VVXV2X-$22.57M$1.29159.979.370.610.22%13.49%4.29%8/5/2025 (Estimated)Latest BEVFF, VVX, ASTH, and GDRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025ASTHAstrana Health$0.23$0.14-$0.09$0.14$628.11 million$620.39 million5/7/2025Q1 2025GDRXGoodRx$0.04$0.09+$0.05$0.03$202.25 million$202.97 million5/5/2025Q1 2025VVXV2X$0.92$0.98+$0.06$0.25$1.04 billion$1.02 billion3/24/2025Q4 2024BEVFFDiversified Royalty$0.04$0.05+$0.01$0.02$17.81 million$12.75 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTHAstrana HealthN/AN/AN/AN/AN/ABEVFFDiversified Royalty$0.177.93%N/A130.77%N/AGDRXGoodRxN/AN/AN/AN/AN/AVVXV2XN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTHAstrana Health0.601.911.91BEVFFDiversified Royalty0.914.284.28GDRXGoodRx0.705.485.48VVXV2X1.091.081.08Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTHAstrana Health52.77%BEVFFDiversified RoyaltyN/AGDRXGoodRx63.77%VVXV2X95.18%Insider OwnershipCompanyInsider OwnershipASTHAstrana Health20.00%BEVFFDiversified Royalty12.00%GDRXGoodRx4.53%VVXV2X1.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTHAstrana Health1,90056.06 million51.49 millionOptionableBEVFFDiversified Royalty39169.03 million147.06 millionNot OptionableGDRXGoodRx950357.17 million365.25 millionOptionableVVXV2X8,10031.68 million31.21 millionOptionableBEVFF, VVX, ASTH, and GDRX HeadlinesRecent News About These CompaniesSquarepoint Ops LLC Purchases Shares of 14,639 V2X, Inc. (NYSE:VVX)June 3 at 3:57 AM | marketbeat.comMillennium Management LLC Purchases 7,682 Shares of V2X, Inc. (NYSE:VVX)June 3 at 3:29 AM | marketbeat.comBank of America Corp DE Trims Position in V2X, Inc. (NYSE:VVX)June 2 at 3:32 AM | marketbeat.comV2X, Inc. (NYSE:VVX) Stock Holdings Lifted by Two Sigma Investments LPJune 1 at 3:59 AM | marketbeat.comAmeriprise Financial Inc. Boosts Stake in V2X, Inc. (NYSE:VVX)June 1 at 3:19 AM | marketbeat.comNuveen Asset Management LLC Acquires 56,349 Shares of V2X, Inc. (NYSE:VVX)May 30, 2025 | marketbeat.comInsider Selling: V2X, Inc. (NYSE:VVX) SVP Sells 2,200 Shares of StockMay 29, 2025 | marketbeat.comMan Group plc Invests $273,000 in V2X, Inc. (NYSE:VVX)May 29, 2025 | marketbeat.comVoloridge Investment Management LLC Buys Shares of 113,232 V2X, Inc. (NYSE:VVX)May 28, 2025 | marketbeat.comV2X, Inc. (NYSE:VVX) Receives $63.67 Consensus PT from BrokeragesMay 28, 2025 | americanbankingnews.comV2X, Inc. (NYSE:VVX) Given Average Rating of "Moderate Buy" by AnalystsMay 26, 2025 | marketbeat.comPoint72 Asset Management L.P. Makes New $818,000 Investment in V2X, Inc. (NYSE:VVX)May 25, 2025 | marketbeat.comV2X (NYSE:VVX) Shares Gap Up - What's Next?May 24, 2025 | marketbeat.comZimmer Partners LP Has $18.64 Million Holdings in V2X, Inc. (NYSE:VVX)May 22, 2025 | marketbeat.comV2X, Inc. (NYSE:VVX) Shares Acquired by D. E. Shaw & Co. Inc.May 22, 2025 | marketbeat.comNorthern Trust Corp Buys 26,461 Shares of V2X, Inc. (NYSE:VVX)May 22, 2025 | marketbeat.comBNP Paribas Financial Markets Buys 19,871 Shares of V2X, Inc. (NYSE:VVX)May 20, 2025 | marketbeat.comSandia Investment Management LP Purchases Shares of 5,500 V2X, Inc. (NYSE:VVX)May 19, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Increases Stock Holdings in V2X, Inc. (NYSE:VVX)May 17, 2025 | marketbeat.comV2X, INC. ANNOUNCES SALE OF 2,000,000 SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACEMay 15, 2025 | prnewswire.com7,342 Shares in V2X, Inc. (NYSE:VVX) Acquired by Algert Global LLCMay 15, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBEVFF, VVX, ASTH, and GDRX Company DescriptionsAstrana Health NASDAQ:ASTH$25.19 +0.69 (+2.82%) Closing price 04:00 PM EasternExtended Trading$25.19 0.00 (0.00%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Diversified Royalty OTCMKTS:BEVFF$2.14 +0.00 (+0.21%) As of 03:26 PM EasternDiversified Royalty Corp., a multi-royalty corporation, engages in the acquisition of royalties from multi-location businesses and franchisors in North America. It owns the Sutton, Mr. Lube + Tires, AIR MILES, Mr. Mikes, Nurse Next Door, Oxford Learning Centres, Stratus Building Solutions, and BarBurrito trademarks. The company was formerly known as BENEV Capital Inc. and changed its name to Diversified Royalty Corp. in September 2014. Diversified Royalty Corp. was founded in 1960 and is headquartered in Vancouver, Canada.GoodRx NASDAQ:GDRX$3.94 +0.12 (+3.14%) Closing price 04:00 PM EasternExtended Trading$3.94 0.00 (-0.13%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.V2X NYSE:VVX$44.79 +1.03 (+2.35%) Closing price 03:59 PM EasternExtended Trading$45.10 +0.31 (+0.70%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.V2X, Inc. provides critical mission solutions and support services to defense clients worldwide. It offers a suite of integrated solutions across the operations and logistics, aerospace, training, and technology markets to national security, defense, civilian, and international clients. The company was incorporated in 2014 and is headquartered in Mclean, Virginia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.